[Duration of antiretroviral combinations]

Med Clin (Barc). 2004 May 15;122(18):696-7. doi: 10.1016/s0025-7753(04)74359-6.
[Article in Spanish]
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active*
  • HIV Infections / drug therapy*
  • HIV-1*
  • Humans
  • Risk Factors
  • Time Factors
  • Treatment Failure

Substances

  • Anti-HIV Agents